DALL'OLIO, FILIPPO GUSTAVO
 Distribuzione geografica
Continente #
NA - Nord America 256
EU - Europa 94
AS - Asia 28
SA - Sud America 2
AF - Africa 1
Totale 381
Nazione #
US - Stati Uniti d'America 254
IT - Italia 35
FR - Francia 16
IE - Irlanda 14
DE - Germania 7
JP - Giappone 7
GB - Regno Unito 6
IN - India 6
NL - Olanda 6
VN - Vietnam 4
BG - Bulgaria 3
CN - Cina 3
AE - Emirati Arabi Uniti 2
CA - Canada 2
HK - Hong Kong 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
CZ - Repubblica Ceca 1
FI - Finlandia 1
ID - Indonesia 1
JO - Giordania 1
PL - Polonia 1
RU - Federazione Russa 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 381
Città #
Ashburn 175
Dublin 14
Bologna 7
New York 5
Santa Cruz 4
Berlin 3
Fairfield 3
Milan 3
Reggio Emilia 3
Seattle 3
Sofia 3
Southend 3
Amsterdam 2
Belgrade 2
Boardman 2
Buffalo 2
Cascina 2
Cesena 2
Council Bluffs 2
Dallas 2
Koto 2
Lyon 2
Nadiad 2
Paris 2
Piura 2
Providence 2
Rome 2
San Diego 2
Toronto 2
Woodbridge 2
Amman 1
Andover 1
Ann Arbor 1
Atlanta 1
Basking Ridge 1
Briosco 1
Cambridge 1
Castiglione delle Stiviere 1
Cedar Knolls 1
Cerzat 1
Chennai 1
Chicago 1
Columbus 1
Dong Ket 1
Ferrara 1
Genoa 1
Guangzhou 1
Hanoi 1
Helsinki 1
Hollywood 1
Houston 1
Kowloon 1
Lake Forest 1
Leiderdorp 1
London 1
Los Angeles 1
Mesagne 1
Milpitas 1
Minamishibetsucho 1
Mountain View 1
Muizenberg 1
Munich 1
Naples 1
New Orleans 1
New Providence 1
Nijmegen 1
Orte 1
Osaka 1
Pilsen 1
Pistoia 1
Romentino 1
San Francisco 1
San Jose 1
Shizuoka 1
Sucha Beskidzka 1
Tokyo 1
Trieste 1
Wilmington 1
Totale 310
Nome #
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors, file e1dcb336-dabb-7715-e053-1705fe0a6cc9 177
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC, file 28899f79-67a6-44a4-b322-8d74d3035641 108
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression, file e1dcb33a-0f68-7715-e053-1705fe0a6cc9 26
Tumor growth rate decline despite progressive disease may predict improved nivolumab treatment outcome in mrcc: When recist is not enough, file db400b10-d63b-4046-9736-4b6f24296825 23
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience, file e1dcb339-d452-7715-e053-1705fe0a6cc9 23
Expected and non-expected immune-related adverse events detectable by CT, file e1dcb338-a088-7715-e053-1705fe0a6cc9 19
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations, file 222b91e3-bd01-4fe2-a46f-6955d14762ca 2
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations, file 7ae06153-19d3-4683-b009-351ec0180613 1
The EGFR exon 19 mutant L747-A750>P exhibits distinct sensitivity to tyrosine kinase inhibitors in lung adenocarcinoma—letter, file e1dcb333-d5b7-7715-e053-1705fe0a6cc9 1
Immortal time bias question in the association between toxicity and outcome of immune checkpoint inhibitors, file e1dcb335-04a7-7715-e053-1705fe0a6cc9 1
Totale 381
Categoria #
all - tutte 1.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/202118 1 0 0 0 0 0 0 2 2 4 2 7
2021/202239 1 0 1 1 2 4 2 5 1 5 10 7
2022/202385 4 1 7 13 8 3 6 5 19 8 9 2
2023/2024238 6 2 7 13 5 13 179 5 7 0 1 0
Totale 381